Decreasing potassium conductance: a possible mechanism of supersensitivity and hyperreactivity of coronary artery to prostaglandins, thromboxane A2, and ergonovine.
D000818:Animals; D003329:Coronary Vasospasm / Q000209:etiology*; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology*; D004285:Dogs; D004874:Ergonovine / Q000494:pharmacology*; D066298:In Vitro Techniques; D011188:Potassium / Q000378:metabolism*; D011453:Prostaglandins / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000494:pharmacology*
D011453:Prostaglandins; D013928:Thromboxane A2; D011188:Potassium; D004874:Ergonovine